Search results
Found 1358 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford vaccine researchers talk research and home-schooling on ITV's This Morning
Coronavirus COVID-19 General Research
7 January 2021
Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.
MRC HIU appoints new Director
Awards and Appointments General
6 January 2021
We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.
Potential New Target to Prevent or Delay Dementia
General Research
5 January 2021
New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.
UK National Health Service begins rollout of Oxford coronavirus vaccine
Coronavirus COVID-19 General
4 January 2021
At 7.30 am today, dialysis patient Brian Pinker became the very first person to be vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, with patients at the Oxford University NHS Hospitals Trust becoming the first to receive this life-saving vaccine.
New Year's Honours 2021
Awards and Appointments General
1 January 2021
Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.
Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
30 December 2020
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research
Coronavirus COVID-19 General Research
18 December 2020
In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.
Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease
Awards and Appointments General
18 December 2020
Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.
Oxford academics team up with charity to help disadvantaged babies & toddlers
Coronavirus COVID-19 General
17 December 2020
Developmental psychologists at University of Oxford and Oxford Brookes University have raised enough money to provide outdoor baby and toddler weather gear for 70 local families. The rain-sets, provided at discount by Wet Wednesdays, have been distributed by volunteers from Home-Start Oxford to disadvantaged families struggling this winter.
Professor Sir Rory Collins awarded the MRC Millennium Medal 2020
Awards and Appointments General
17 December 2020
Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.
Launch of new Scan Academy webinars
General Research
16 December 2020
Nuffield Department of Women's and Reproductive Health celebrate the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.
Plastic surgeons recommend a review of cancer excision guidelines after finding variations in effectiveness
General Research
15 December 2020
A systematic review finds incomplete excision rates for basal cell carcinoma range from 4.7% to 20.4%, against recommended guidelines of 5%.
COVID-19 vaccine hesitancy in the UK
Coronavirus COVID-19 General
14 December 2020
The pandemic is testing our societal structures like never before. To deal with it successfully, we need to think and act collectively, led by our key institutions. But at a time when unity is critical, are we about to see the effects of a long-standing and corrosive drip feed of mistrust?
Cochrane ENT awarded NIHR funding for COVID-19 project
Coronavirus COVID-19 General Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
National COVID-19 Infections Survey reveals changes to pandemic over time
Coronavirus COVID-19 General Research
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.
Key step for hepatitis research as patient database created
General Research
11 December 2020
For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions.
University spinout PepGen awarded major financing to target Duchenne muscular dystrophy
Awards and Appointments General Innovation
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships
Awards and Appointments General Innovation
9 December 2020
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
University of Oxford awarded major European Research Council funding
Awards and Appointments General Research
9 December 2020
European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.